SCHEMBL626734

SCHEMBL626734

COC(=O)CC(C#N)(Cc1ccccc1)c1cccc(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.39
CTSL P07711 3/20 0.37
CTSB P07858 2/20 0.37
KIF11 P52732 3/20 0.37
CTSS P25774 1/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAOB P27338 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL623297 0.87 LMNA (0.43) ATMKIF11LMNACYP3A4
SCHEMBL622078 0.87 USP2 (0.43) CTSLRAB9ANPC1MEN1KMT2A
SCHEMBL10249718 0.85 EGLN1 (0.37) ATMLMNAALDH1A1CYP3A4CYP2C9
SCHEMBL4431139 0.79 CNR1 (0.41) KIF11LMNAALDH1A1KMT2APOLB
SCHEMBL11819398 0.77 LMNA (0.41) KIF11RAB9ANPC1LMNAL3MBTL1
SCHEMBL10249534 0.76 RAB9A (0.42) CTSLRAB9ANPC1MEN1KMT2A
SCHEMBL4496567 0.72 ALDH1A1 (0.45) ALDH1A1CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL11819407 0.71 LMNA (0.37) CTSLKIF11RAB9ALMNAL3MBTL1
SCHEMBL4005284 0.71 KIF11 (0.45) KIF11RAB9ANPC1LMNAALDH1A1
SCHEMBL14297778 0.69 KIF11 (0.46) KIF11RAB9ANPC1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2603487-A1 PHENALKYLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY Abbott GmbH & Co. KG (DE) 2013-06-19 EP disclosed
WO-2012020130-A1 PHENALKYLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY ABBOTT GMBH & CO. KG (DE) 2012-02-16 WO disclosed